MedTrace Logo

The Clinical Carbetocin Myocardium Trial

NCT02528136 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-06-14

No results posted yet for this study

Summary

Randomized comparison of different cardiotoxicity of carbetocin and oxytocin.

Conditions

  • Pregnancy

Interventions

DRUG

Carbetocin

DRUG

Oxytocin

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Leiv Arne Rosseland, PhD · Dep of Research and Development, Division of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2019-01-28
Completion
2019-01-28

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02528136 on ClinicalTrials.gov